J. Christopher Naftzger
CIK 1496194 · General Counsel and CCO · last filed 2025-02-19
J. Christopher Naftzger is a General Counsel and CCO who has filed 15 SEC Form 4 insider transactions across 3 companies since 2010. The most recent filing, for ABUS, was dated Feb 19, 2025. Across all open-market trades the lifetime net is −$11.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $598.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$598.7K
3
15
-$11.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ABUS | General Counsel and CCO | 140,544 | $4.26 | $598.7K | -$37.2K | 4 | 2025-02-19 |
| Nabriva Therapeutics plc (NBRV) Delisted | General Counsel and Corp Sec | 7,000 | $1.42 | $9.9K | $4.1K | 4 | 2022-08-15 |
| Unilife Corp (UNIS) Delisted | See Remarks | 224,440 | — | — | $22.0K | 7 | 2013-05-30 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-19 | ABUS | Grant (A) | +54,300 | $0 | EDGAR |
| 2025-02-05 | ABUS | Sell (S) | −11,333 | -$37.2K | EDGAR |
| 2024-02-05 | ABUS | Grant (A) | +95,100 | $0 | EDGAR |
| 2023-07-12 | ABUS | Grant (A) | — | $0 | EDGAR |
| 2022-08-15 | Nabriva Therapeutics plc (NBRV) Delisted | Exer (M) | — | $0 | EDGAR |
| 2022-02-01 | Nabriva Therapeutics plc (NBRV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-28 | Nabriva Therapeutics plc (NBRV) Delisted | Buy (P) | +7,000 | $4.1K | EDGAR |
| 2021-10-01 | Nabriva Therapeutics plc (NBRV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-05-30 | Unilife Corp (UNIS) Delisted | Grant (A) | +165,000 | $0 | EDGAR |
| 2012-03-22 | Unilife Corp (UNIS) Delisted | Grant (A) | +17,500 | $0 | EDGAR |